AtaiBeckley ATAI
US equityBiotechnology
$0.00 +$0.00 (0.00%)
Market closed · Nov 20, 9:30 am ET
Open$0.00
Prev close$0.00
Day range$0.00 – $0.00
Volume0.00
Market cap–
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q2, ended Jun 2026
Revenue$1.70M+137.0% YoY
Operating profit-$41.72M-65.3% YoY
Net profit-$32.55M-17.3% YoY
Diluted EPS-$0.09+35.7% YoY
Free cash flow-$35.27M-148.0% YoY
Operating cash flow-$35.27M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Operating margin-3,122.6%
Net margin-14,941.7%
Return on equity-417.5%
Return on assets-294.4%
Return on invested capital-403.9%
Current ratio8.58
Liabilities / assets33.4%
Cash & investments$225.81M
Total debt$1.57M
Net cash (debt)$224.24M
Income statement
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $1.70M | $954,000.00 | $4.09M | $1.07M | $749,000.00 |
| Total Operating Revenue | $1.70M | $954,000.00 | $4.09M | $1.07M | $749,000.00 |
| Operating Expense | $43.43M | $31.11M | $117.44M | $40.42M | $29.16M |
| Selling and Admin Expenses | $17.77M | $14.44M | $65.09M | $25.09M | $14.51M |
| -General & Admin Expense | $17.77M | $14.44M | $65.09M | $25.09M | $14.51M |
| Research & Development | $28.07M | $17.41M | $53.06M | $15.96M | $14.68M |
| Other Operating Expenses | -$2.42M | -$742,000.00 | – | – | -$29,000.00 |
| Operating Profit | -$41.72M | -$30.16M | -$113.35M | -$39.35M | -$28.41M |
| Net Non-Operating Interest Income (Expense) | $79,000.00 | $78,000.00 | $316,000.00 | $542,000.00 | $504,000.00 |
| Non-Operating Interest Income | $79,000.00 | $78,000.00 | $1.48M | $540,000.00 | $504,000.00 |
| Non-Operating Interest Expense | $0.00 | $0.00 | $1.16M | -$2,000.00 | $0.00 |
| Other Income (Expense) | $9.16M | $299,000.00 | -$546.82M | -$506.11M | -$33.06M |
| Gain on Sale of Security | $9.99M | $2.18M | -$18.71M | $20.69M | -$32.61M |
| Special Income (Charges) | $0.00 | – | -$525.52M | -$524.20M | $0.00 |
| Other Non-Operating Income (Expenses) | -$828,000.00 | -$1.88M | -$2.59M | -$2.60M | -$451,000.00 |
| Pretax Profit | -$32.48M | -$29.78M | -$659.85M | -$544.92M | -$60.97M |
| Tax | $64,000.00 | $20,000.00 | $298,000.00 | -$82,000.00 | $131,000.00 |
| Net Profit | -$32.55M | -$29.80M | -$660.15M | -$544.84M | -$61.10M |
| Profit from Continuing Operations | -$32.55M | -$29.80M | -$660.15M | -$544.84M | -$61.10M |
| Minority Interests | -$24,000.00 | -$20,000.00 | -$100,000.00 | -$25,000.00 | -$24,000.00 |
| Net Income to Parent Company | -$32.52M | -$29.78M | -$660.05M | -$544.81M | -$61.07M |
| Net Income to Common Stockholders | -$32.52M | -$29.78M | -$660.05M | -$544.81M | -$61.07M |
| Basic EPS | -$0.09 | -$0.08 | -$2.91 | -$1.73 | -$0.28 |
| Diluted EPS | -$0.09 | -$0.08 | -$2.91 | -$1.73 | -$0.28 |
| Other Taxes | – | – | -$714,000.00 | – | – |
| -Less:Other Special Charges | – | – | $524.82M | $523.51M | – |
| -Gain on Sale Of Business | – | – | $0.00 | – | – |
| -Gain on Sale of Property/Plant/Equipment | – | – | -$692,000.00 | – | – |
| – | – | $0.00 | $0.00 | $0.00 |
Balance sheet
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $264.79M | $264.88M | $292.72M | $292.72M | $239.82M |
| Total Current Assets | $244.75M | $250.07M | $275.68M | $275.68M | $130.67M |
| Cash and Cash Equivalents & Short-Term Investments | $225.81M | $230.77M | $256.04M | $256.04M | $114.61M |
| -Cash and Cash Equivalents | $168.81M | $43.10M | $85.30M | $85.30M | $30.40M |
| -Short Term Investments | $57.00M | $187.67M | $170.74M | $170.74M | $84.20M |
| Receivables | $10.70M | $14.71M | $14.43M | $14.43M | $11.07M |
| -Accounts Receivable | $647,000.00 | $864,000.00 | $667,000.00 | $667,000.00 | – |
| -Notes Receivable | $107,000.00 | $691,000.00 | $625,000.00 | $625,000.00 | $10.16M |
| -Taxes Receivable | $9.94M | $13.15M | $13.14M | $13.14M | $907,000.00 |
| Prepaid Assets | $6.53M | $2.85M | $4.27M | $4.27M | $3.99M |
| Other Current Assets | $1.72M | $1.74M | $946,000.00 | $946,000.00 | $1.00M |
| Total Non-Current Assets | $20.04M | $14.81M | $17.04M | $17.04M | $109.15M |
| Net PPE | $3.65M | $3.86M | $4.01M | $4.01M | $5.67M |
| -Gross PPE | $4.27M | $4.35M | $4.42M | $4.42M | $6.41M |
| -Accumulated Depreciation | -$617,000.00 | -$485,000.00 | -$405,000.00 | -$405,000.00 | -$733,000.00 |
| Investments and Advances | $5.86M | $6.77M | $8.74M | $8.74M | $88.36M |
| Goodwill and Other Intangible Assets | $3.03M | $3.09M | $3.18M | $3.18M | $14.74M |
| -Goodwill | $331,000.00 | $331,000.00 | $331,000.00 | $331,000.00 | $331,000.00 |
| -Other Intangible Assets | $2.70M | $2.76M | $2.85M | $2.85M | $14.41M |
| Other Non-Current Assets | $7.50M | $1.09M | $1.11M | $1.11M | $382,000.00 |
| Total Liabilities | $88.36M | $66.10M | $70.72M | $70.72M | $79.91M |
| Total Current Liabilities | $28.53M | $24.96M | $23.48M | $23.48M | $16.54M |
| Payables | $11.61M | $10.86M | $4.93M | $4.93M | $5.41M |
| -Accounts Payable | $11.49M | $10.79M | $4.91M | $4.91M | $5.37M |
| -Total Tax Payable | $114,000.00 | $75,000.00 | $20,000.00 | $20,000.00 | $43,000.00 |
| Current Accrued Expenses | $13.06M | $9.59M | $13.61M | $13.61M | $9.93M |
| Short-Term Debt and Capital Lease Obligation | $314,000.00 | $310,000.00 | $271,000.00 | $271,000.00 | $532,000.00 |
| -Current Capital Lease Obligation | $314,000.00 | $310,000.00 | $271,000.00 | $271,000.00 | $532,000.00 |
| Current Deferred Liabilities | $632,000.00 | $1.48M | $1.52M | $1.52M | – |
| Other Current Liabilities | $2.92M | $2.72M | $3.14M | $3.14M | $665,000.00 |
| Total Non-Current Liabilities | $59.82M | $41.13M | $47.24M | $47.24M | $63.37M |
| Long Term Debt and Capital Lease Obligation | $1.57M | $1.69M | $1.80M | $1.80M | $2.43M |
| -Long Term Capital Lease Obligation | $1.57M | $1.69M | $1.80M | $1.80M | $2.43M |
| Derivative Product Liabilities | $57.21M | $38.40M | $44.38M | $44.38M | $57.43M |
| Other Non-Current Liabilities | $1.04M | $1.05M | $1.06M | $1.06M | $3.51M |
| Total Equity | $176.44M | $198.78M | $222.00M | $222.00M | $159.91M |
| Stockholders' Equity | $176.37M | $198.68M | $221.87M | $221.87M | $159.75M |
| Capital Stock | $3.69M | $3.66M | $3.63M | $3.63M | $26.78M |
| -Common Stock | $3.69M | $3.66M | $3.63M | $3.63M | $26.78M |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | – |
| Additional Paid-In Capital | $1.62B | $1.61B | $1.60B | $1.60B | $969.38M |
| Retained Earnings | -$1.42B | -$1.39B | -$1.36B | -$1.36B | -$815.44M |
| Gains/Losses Not Affecting Retained Earnings | -$20.47M | -$20.60M | -$20.93M | -$20.93M | -$20.96M |
| Minority Interests | $71,000.00 | $96,000.00 | $127,000.00 | $127,000.00 | $157,000.00 |
| Restricted Cash | – | – | $0.00 | $0.00 | $0.00 |
| -Available for Sale Securities | – | – | – | – | $53.95M |
| -Long Term Equity Investment | – | – | – | – | $34.41M |
Cash flow
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$35.27M | -$21.09M | -$102.68M | -$47.48M | -$23.26M |
| Net cash flow from continuing operations | -$35.27M | -$21.09M | -$102.68M | -$47.48M | -$23.26M |
| Net Income from Continuing Operations | -$32.55M | -$29.80M | -$660.15M | -$544.84M | -$61.10M |
| Gain/Loss from Continuing Operations | $2,000.00 | $372,000.00 | $521.88M | $522.00M | $4.30M |
| Depreciation & Depletion & Amortization | $215,000.00 | $167,000.00 | $1.01M | $336,000.00 | $233,000.00 |
| Other Non-Cash Items | -$8.46M | -$1.26M | $26.81M | -$20.02M | $31.46M |
| Change in Working Capital | -$2.83M | $2.02M | -$6.48M | -$11.29M | -$1.26M |
| -Change in Prepaid Assets | -$241,000.00 | $183,000.00 | $691,000.00 | -$1.22M | $427,000.00 |
| -Change in Payables and Accrued Expense | $4.77M | $1.85M | -$7.93M | -$10.84M | -$2.22M |
| -Change In Other Working Capital | -$7.36M | -$19,000.00 | $766,000.00 | – | – |
| Net cash flow from investing | $158.59M | -$21.65M | -$109.13M | -$40.34M | -$67.55M |
| Net Cash Flow from Continuing Investing Activities | $158.59M | -$21.65M | -$109.13M | -$40.34M | -$67.55M |
| Net PPE Purchase and Sale | $0.00 | $0.00 | -$901,000.00 | -$110,000.00 | $4.60M |
| Net Investment Purchase and Sale | $158.59M | -$21.65M | -$92.90M | -$47.87M | -$49.94M |
| Financing Cash Flow | $2.64M | $821,000.00 | $269.48M | $142.38M | $59.74M |
| Net Cash Flow from Continuing Financing Activities | $2.64M | $821,000.00 | $269.48M | $142.38M | $59.74M |
| Net Common Stock Issuance | $0.00 | $0.00 | $251.49M | $139.06M | $36.44M |
| Proceeds from Stock Option Exercised | $2.64M | $821,000.00 | $31.94M | $24.81M | -$6.06M |
| Ending Cash Balance | $168.81M | $43.10M | $85.30M | $85.30M | $30.40M |
| Net Change in Cash | $125.95M | -$41.92M | $57.68M | $54.55M | -$31.07M |
| Beginning Cash Balance | $43.10M | $85.30M | $27.51M | $30.40M | $61.94M |
| Effect of Exchange Rate Changes | -$248,000.00 | -$276,000.00 | $116,000.00 | $346,000.00 | -$468,000.00 |
| Free Cash Flow | -$35.27M | -$21.09M | -$113.54M | -$47.59M | -$28.62M |
| Net Intangibles Purchase and Sale | – | $0.00 | -$9.97M | $0.00 | – |
| Capital Expenditure | – | – | $0.00 | $0.00 | $0.00 |
| Net Business Purchase and Sale | – | – | $4.64M | $7.64M | -$2.25M |
| Net Other Investing Changes | – | – | -$10.00M | $0.00 | – |
| Net Issuance Payments Of Debt | – | – | $0.00 | $0.00 | $21.81M |
| Net Other Financing Charges | – | – | -$13.95M | $0.00 | – |
No comments yet — be the first to weigh in on ATAI.
Sign in to join the discussion.